Pipeline
Overview
NeuraLight is a part of multiple clinical partnerships for different CNS diseases conducted in leading medical centers worldwide. More information can be found here.
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Healthy Subjects | ||||
| Parkinson’s Disease (PD) | ||||
| Amyotrophic Lateral Sclerosis (ALS) | ||||
| Multiple Sclerosis (MS) | ||||
| Progressive Supranuclear Palsy (PSP) | ||||
| Multiple System Atrophy (MSA) | ||||
| Huntington’s disease (HD) | ||||
Partnerships
Partner with us to accelerate your CNS drug development
